← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Precision Optics Corporation, Inc. (POCI) 10-Year Financial Performance & Capital Metrics

POCI • • Industrial / General
HealthcareMedical InstrumentsSurgical & Interventional DevicesSurgical Instruments & Tools
AboutPrecision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.Show more
  • Revenue $19M
  • EBITDA -$5M -112.5%
  • Net Income -$6M -95.8%
  • EPS (Diluted) -0.85 -73.5%
  • Gross Margin 17.83% -41.2%
  • EBITDA Margin -27.96% -112.7%
  • Operating Margin -29.08% -103.9%
  • Net Margin -30.28% -96.0%
  • ROE -51.78% -94.0%
  • ROIC -32.5% -101.8%
  • Debt/Equity 0.17 -51.3%
  • Interest Coverage -24.45 -102.1%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Strong 5Y sales CAGR of 14.0%

✗Weaknesses

  • ✗Weak Piotroski F-Score: 3/9
  • ✗Negative free cash flow
  • ✗Shares diluted 11.9% in last year

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y17.18%
5Y13.98%
3Y6.79%
TTM13.67%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-
TTM-60.76%

EPS CAGR

10Y-
5Y-
3Y-
TTM-36.61%

ROCE

10Y Avg-57.05%
5Y Avg-22.35%
3Y Avg-22.89%
Latest-43.29%

Peer Comparison

Surgical Instruments & Tools
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
PDEXPro-Dex, Inc.136.12M41.7315.6323.68%15.93%26.96%0.45
POCIPrecision Optics Corporation, Inc.33.79M4.38-5.15-0.07%-28.3%-55.9%0.17

Profit & Loss

Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Sales/Revenue+3.92M3.15M4.04M6.8M9.92M10.67M15.68M21.04M19.1M19.09M
Revenue Growth %0%-0.19%0.28%0.69%0.46%0.08%0.47%0.34%-0.09%-0%
Cost of Goods Sold+2.97M2.38M2.56M4.68M6.56M7.24M10.75M13.31M13.31M15.69M
COGS % of Revenue0.76%0.75%0.63%0.69%0.66%0.68%0.69%0.63%0.7%0.82%
Gross Profit+942.02K773.72K1.48M2.12M3.36M3.43M4.93M7.73M5.8M3.4M
Gross Margin %0.24%0.25%0.37%0.31%0.34%0.32%0.31%0.37%0.3%0.18%
Gross Profit Growth %0.18%-0.18%0.92%0.43%0.58%0.02%0.44%0.57%-0.25%-0.41%
Operating Expenses+2M1.78M1.83M2.61M4.79M4.34M6.28M8.37M8.52M8.96M
OpEx % of Revenue0.51%0.56%0.45%0.38%0.48%0.41%0.4%0.4%0.45%0.47%
Selling, General & Admin1.55M1.31M1.37M2.1M3.9M3.71M5.61M7.38M7.54M7.8M
SG&A % of Revenue0.4%0.42%0.34%0.31%0.39%0.35%0.36%0.35%0.39%0.41%
Research & Development478.27K464.16K456.38K505.3K886.13K624.25K666.48K992.38K981.78K1.16M
R&D % of Revenue0.12%0.15%0.11%0.07%0.09%0.06%0.04%0.05%0.05%0.06%
Other Operating Expenses-32.71K000000000
Operating Income+-1.06M-1M-348.62K-612.54K-1.42M-905.58K-1.35M-638.55K-2.72M-5.55M
Operating Margin %-0.27%-0.32%-0.09%-0.09%-0.14%-0.08%-0.09%-0.03%-0.14%-0.29%
Operating Income Growth %0.13%0.05%0.65%-0.76%-1.32%0.36%-0.49%0.53%-3.27%-1.04%
EBITDA+-1.03M-968.74K-321.4K-573.99K-1.31M-758.78K-1.11M-427.81K-2.51M-5.34M
EBITDA Margin %-0.26%-0.31%-0.08%-0.08%-0.13%-0.07%-0.07%-0.02%-0.13%-0.28%
EBITDA Growth %0.14%0.06%0.67%-0.79%-1.28%0.42%-0.46%0.61%-4.87%-1.13%
D&A (Non-Cash Add-back)25.86K33.66K27.22K38.55K112.22K146.8K245.24K210.74K212.38K212.44K
EBIT-1.03M-1M-348.62K-612.54K-1.42M-96.62K-771.81K76.25K-2.72M-5.55M
Net Interest Income+-469-3.14K-1.86K-1.42K-1K-5.3K-155.66K-218.93K-225.11K-227.02K
Interest Income0000000000
Interest Expense4693.14K1.86K1.42K1K5.3K155.66K218.93K225.11K227.02K
Other Income/Expense21.58K-3.14K-1.86K-1.42K-1K803.66K586.43K495.87K-225.11K-227.02K
Pretax Income+-1.03M-1.01M-350.48K-613.96K-1.42M-101.92K-927.46K-142.68K-2.95M-5.78M
Pretax Margin %-0.26%-0.32%-0.09%-0.09%-0.14%-0.01%-0.06%-0.01%-0.15%-0.3%
Income Tax+9129129129122.17K9129521.94K1.94K1.94K
Effective Tax Rate %1%1%1%1%1%1.01%1%1.01%1%1%
Net Income+-1.03M-1.01M-351.39K-614.87K-1.43M-102.83K-928.42K-144.61K-2.95M-5.78M
Net Margin %-0.26%-0.32%-0.09%-0.09%-0.14%-0.01%-0.06%-0.01%-0.15%-0.3%
Net Income Growth %0.12%0.03%0.65%-0.75%-1.32%0.93%-8.03%0.84%-19.41%-0.96%
Net Income (Continuing)-1.03M-1.01M-351.39K-614.87K-1.43M-102.83K-928.42K-144.61K-2.95M-5.78M
Discontinued Operations0000000000
Minority Interest0000000000
EPS (Diluted)+-0.43-0.36-0.11-0.16-0.33-0.02-0.18-0.03-0.49-0.85
EPS Growth %0.23%0.16%0.69%-0.45%-1.06%0.93%-6.76%0.86%-18.22%-0.73%
EPS (Basic)-0.45-0.36-0.11-0.16-0.33-0.02-0.18-0.03-0.49-0.85
Diluted Shares Outstanding2.39M2.78M3.28M3.83M4.33M4.43M5.3M5.67M6.07M6.79M
Basic Shares Outstanding2.3M2.78M3.28M3.83M4.33M4.43M5.3M5.67M6.07M6.79M
Dividend Payout Ratio----------

Balance Sheet

Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Total Current Assets+2.02M1.7M2.41M6.37M4.95M4.78M6.51M9.86M7.12M10.06M
Cash & Short-Term Investments50.06K118.41K402.74K2.29M1.13M861.65K605.75K2.93M405.28K1.77M
Cash Only50.06K118.41K402.74K2.29M1.13M861.65K605.75K2.93M405.28K1.77M
Short-Term Investments0000000000
Accounts Receivable750.38K468.55K796.92K2.17M1.48M1.88M2.66M3.91M3.55M4.34M
Days Sales Outstanding69.9354.2172.03116.1454.4964.2462.0267.7767.7482.91
Inventory1.13M1.06M1.14M1.73M2.2M1.89M3.02M2.78M2.87M3.56M
Days Inventory Outstanding139.08161.81163.37135.24122.2495.03102.6176.1378.6782.88
Other Current Assets0000000000
Total Non-Current Assets+101.07K102.34K96.76K1.12M1.4M1.48M10.2M9.88M9.79M9.73M
Property, Plant & Equipment78.19K72.25K49.49K383.01K621.55K655.5K1.15M791.96K683.57K675.62K
Fixed Asset Turnover50.09x43.66x81.60x17.77x15.97x16.29x13.69x26.57x27.95x28.26x
Goodwill000687.66K687.66K687.66K8.82M8.82M8.82M8.82M
Intangible Assets22.87K30.09K47.27K54.09K95.23K141.7K229.4K265.11K286.56K232.49K
Long-Term Investments0000000000
Other Non-Current Assets0000000000
Total Assets+2.12M1.8M2.51M7.49M6.35M6.26M16.7M19.74M16.91M19.79M
Asset Turnover1.84x1.75x1.61x0.91x1.56x1.70x0.94x1.07x1.13x0.96x
Asset Growth %0.04%-0.15%0.39%1.98%-0.15%-0.01%1.67%0.18%-0.14%0.17%
Total Current Liabilities+1.5M1.22M1.93M3.61M3.15M2.51M4.59M5.26M4.91M6.15M
Accounts Payable1.15M694.96K703.54K1.17M1.07M1.21M2.24M2.43M1.4M2.91M
Days Payables Outstanding141.3106.54100.4691.5559.3160.7576.0366.738.3367.69
Short-Term Debt0000808.96K0367.71K513.26K1.28M577.9K
Deferred Revenue (Current)0180.14K857.84K450.19K417.06K450.08K905.11K1000K1000K1000K
Other Current Liabilities25K145.51K123.91K1.44M166.67K166.67K166.67K000
Current Ratio1.34x1.39x1.25x1.76x1.57x1.90x1.42x1.87x1.45x1.64x
Quick Ratio0.59x0.53x0.66x1.28x0.87x1.15x0.76x1.35x0.87x1.06x
Cash Conversion Cycle67.71109.48134.94159.83117.4298.5388.677.2108.0898.11
Total Non-Current Liabilities+31.95K23.56K14.6K505.03K430.39K319.06K3.15M2.43M1.94M1.38M
Long-Term Debt0000001.96M2.18M1.9M1.29M
Capital Lease Obligations31.95K23.56K14.6K5.03K97.06K152.4K478.85K258.24K38.92K90.95K
Deferred Tax Liabilities0000000000
Other Non-Current Liabilities000500K333.33K166.67K705.89K000
Total Liabilities1.54M1.24M1.95M4.12M3.58M2.83M7.73M7.69M6.84M7.53M
Total Debt+39.81K31.95K23.56K14.6K1.01M251.99K3M3.16M3.43M2.04M
Net Debt-10.25K-86.45K-379.18K-2.27M-119.76K-609.66K2.39M233.51K3.03M262.69K
Debt / Equity0.07x0.06x0.04x0.00x0.37x0.07x0.33x0.26x0.34x0.17x
Debt / EBITDA----------
Net Debt / EBITDA----------
Interest Coverage-2250.39x-318.83x-187.53x-432.59x-1422.98x-170.80x-8.68x-2.92x-12.10x-24.45x
Total Equity+587.17K558.38K564.04K3.38M2.77M3.43M8.97M12.05M10.07M12.26M
Equity Growth %-0.12%-0.05%0.01%4.99%-0.18%0.24%1.61%0.34%-0.16%0.22%
Book Value per Share0.250.200.170.880.640.781.692.131.661.81
Total Shareholders' Equity587.17K558.38K564.04K3.38M2.77M3.43M8.97M12.05M10.07M12.26M
Common Stock75.4K88.73K101.97K120.71K131.92K132.82K169.15K60.66K60.74K77.15K
Retained Earnings-43.66M-44.67M-45.02M-45.64M-47.06M-47.17M-48.09M-48.24M-51.19M-56.97M
Treasury Stock0000000000
Accumulated OCI0000000000
Minority Interest0000000000

Cash Flow

Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Cash from Operations+-876.3K-667.43K100.66K-1.03M-592.49K46.55K-933.37K-81.09K-2.68M-3.55M
Operating CF Margin %-0.22%-0.21%0.02%-0.15%-0.06%0%-0.06%-0%-0.14%-0.19%
Operating CF Growth %-0.13%0.24%1.15%-11.25%0.43%1.08%-21.05%0.91%-32.09%-0.32%
Net Income-1.03M-1.01M-351.39K-614.87K-1.43M-102.83K-928.42K-144.61K-2.95M-5.78M
Depreciation & Amortization25.86K33.66K27.22K38.55K112.22K146.8K190.22K210.74K212.38K212.44K
Stock-Based Compensation241.39K201.61K52.34K473.33K502.35K733.93K915.49K919.03K959.78K1.46M
Deferred Taxes-32.71K-1.51K227.5K01.5K00000
Other Non-Cash Items40.95K33.9K2.4K8.08K45K-806.03K-687.07K-701.8K17.5K46.57K
Working Capital Changes-117.02K71.37K142.59K-936.78K172.6K74.69K-423.6K-364.44K-921.3K513.43K
Change in Receivables-162.34K281.83K-555.88K-723.37K682.17K-400.25K-108.14K-1.24M361.92K-791.24K
Change in Inventory-60.2K78K-88.62K137.51K-462.64K311.85K-680.74K245.93K-91.88K-694.01K
Change in Payables261.46K-457.6K48.58K69.36K-108.26K139.14K819.28K193.09K-1.03M1.51M
Cash from Investing+24.11K-33.42K-21.64K-40.3K-1.6M-289.06K-407.8K-52.5K-293.88K-233.47K
Capital Expenditures-8.6K-34.93K-21.64K-146.85K-160.29K-122.4K-152.74K-52.5K-272.44K-227.21K
CapEx % of Revenue0%0.01%0.01%0.02%0.02%0.01%0.01%0%0.01%0.01%
Acquisitions----------
Investments----------
Other Investing00000000-21.45K-6.26K
Cash from Financing+661.2K769.2K205.31K2.96M1.04M-30.53K1.09M2.45M456.32K5.15M
Debt Issued (Net)----------
Equity Issued (Net)----------
Dividends Paid0000000000
Share Repurchases----------
Other Financing-34.64K-2.95K3.71K41.65K8.68K0-129.38K-176.54K12.79K111.7K
Net Change in Cash----------
Free Cash Flow+-884.9K-702.37K79.02K-1.18M-752.78K-75.85K-1.09M-133.59K-2.98M-3.77M
FCF Margin %-0.23%-0.22%0.02%-0.17%-0.08%-0.01%-0.07%-0.01%-0.16%-0.2%
FCF Growth %-0.04%0.21%1.11%-15.91%0.36%0.9%-13.32%0.88%-21.28%-0.27%
FCF per Share-0.37-0.250.02-0.31-0.17-0.02-0.21-0.02-0.49-0.56
FCF Conversion (FCF/Net Income)0.85x0.66x-0.29x1.68x0.42x-0.45x1.01x0.56x0.91x0.61x
Interest Paid000000000216.46K
Taxes Paid9129129129129122.17K9121.94K1.94K1.94K

Key Ratios

Metric2016201720182019202020212022202320242025
Return on Equity (ROE)-165.03%-175.72%-62.61%-31.2%-46.39%-3.32%-14.97%-1.38%-26.69%-51.78%
Return on Invested Capital (ROIC)-157.88%-143.36%-79.62%-71.34%-56.84%-24.82%-14.29%-4.05%-16.1%-32.5%
Gross Margin24.05%24.53%36.7%31.19%33.89%32.16%31.43%36.75%30.35%17.83%
Net Margin-26.42%-31.91%-8.7%-9.04%-14.37%-0.96%-5.92%-0.69%-15.45%-30.28%
Debt / Equity0.07x0.06x0.04x0.00x0.37x0.07x0.33x0.26x0.34x0.17x
Interest Coverage-2250.39x-318.83x-187.53x-432.59x-1422.98x-170.80x-8.68x-2.92x-12.10x-24.45x
FCF Conversion0.85x0.66x-0.29x1.68x0.42x-0.45x1.01x0.56x0.91x0.61x
Revenue Growth0.12%-19.46%28.01%68.5%45.84%7.57%46.87%34.23%-9.22%-0.07%

Revenue by Segment

20212022202320242025
Engineering Design Services2.77M5.37M6.73M8.32M4.94M
Engineering Design Services Growth-93.88%25.27%23.70%-40.67%
Optical Components5.75M6.48M10.52M8.38M-
Optical Components Growth-12.70%62.36%-20.33%-
Medical Device Products And Assemblies--3.79M2.4M-
Medical Device Products And Assemblies Growth----36.79%-
Medical Device-3.82M---
Medical Device Growth-----
Medical Device Products and Assemblies2.15M----
Medical Device Products and Assemblies Growth-----

Frequently Asked Questions

Growth & Financials

Precision Optics Corporation, Inc. (POCI) reported $21.6M in revenue for fiscal year 2025. This represents a 902% increase from $2.2M in 2012.

Precision Optics Corporation, Inc. (POCI) saw revenue decline by 0.1% over the past year.

Precision Optics Corporation, Inc. (POCI) reported a net loss of $6.1M for fiscal year 2025.

Dividend & Returns

Precision Optics Corporation, Inc. (POCI) has a return on equity (ROE) of -51.8%. Negative ROE indicates the company is unprofitable.

Precision Optics Corporation, Inc. (POCI) had negative free cash flow of $3.7M in fiscal year 2025, likely due to heavy capital investments.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.